From ketamine drips to microdosing on LSD, psychedelics are shaking up the way we approach and treat mental health. A growing body of scientific evidence shows that these long-stigmatized substances could be potential antidepressants, alleviating symptoms by slipping into areas of the brain traditional SSRIs can’t reach, and encouraging new neural connections.
